CSF2 and non-small cell lung carcinoma: Our work has identified fractalkine/CX3CL1, GM-CSF, IL-1a, IL-12 (p40), IFN-γ, IP-10, MIP-1b, sCD40l, and VEGF as cytokines of possible clinical importance in NSCLC patients who undergo RT.